Background Multiple sclerosis (MS) commonly affects young adults at the ages 20 to 40
years old, but it can onset at each age. Late-onset multiple sclerosis (LOMS) is defined as …

Background Late-onset multiple sclerosis (LOMS) is most commonly defined as the onset of
the disease's presentations at age 50 or older. There is still much to discover about the …

Background. We examined (1) patient characteristics and disease‐modifying drug (DMD)
exposure in late‐onset (LOMS,≥ 50 years at symptom onset) versus adult‐onset (AOMS, 18 …

Background Today, it is estimated that around 5% of multiple sclerosis (MS) patients are in
the late-onset category (age at disease onset≥ 50). Diagnosis and treatment in this group …

Background & Objectives Published natural history data on late-onset of multiple sclerosis
are limited. We aimed to assess the risk of attaining EDSS 6.0 among patients with late …

Late onset multiple sclerosis (LOMS) is when the first symptom starts after 50 years of age,
representing 4.5% of multiple sclerosis (MS) patients. This study describes the clinical …

Current knowledge indicates that the aging process starts with subclinical changes at the
molecular level. These include the accumulation of mutations, telomere attrition, and …

Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin
(IL)-33, one of the recently discovered members of the IL-1 superfamily, is a dual functional …

Background Prevalence of multiple sclerosis has been increased during the last decades
throughout the world. Epidemiological studies could improve our understanding relating to …

Methods: In this cross-sectional descriptive study, 193 patients with relapsing-remitting
multiple sclerosis were selected by compliance sampling method among the patients who …